Mayne to Market Paxene® in the EU
Business Review Editor
Abstract
Mayne and IVAX entered into distribution agreement to market and distribute IVAX’s injectable cancer treatment, Paxene® in the European Union companies.
Full Text: pdf
Add comment

This work is licensed under a Creative Commons Attribution 3.0 License.